Trial Profile
Patient Preference, Sleep Quality, and Anxiety/Depression: A Randomized Comparison of Etravirine and Efavirenz.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Sep 2011
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Etravirine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms SWITCH-EE
- 09 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2010 Results have been published in AIDS.
- 23 Jul 2010 Results presented at the 18th International AIDS Conference.